REAL-WORLD EVIDENCE OF AUTOMATED INSULIN DELIVERY (AID) USE BY INDIVIDUALS WITH TYPE 2 DIABETES (T2D)

被引：0
|
作者：
Fabris, C. [1 ]
Brown, S. [1 ]
Stumpf, M. [1 ]
Kovatchev, B. [1 ]
机构：
[1] Univ Virginia, Ctr Diabet Technol, Charlottesville, VA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
777
引用
收藏
页码：A48 / A48
页数：1
相关论文
共 50 条
  • [21] Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID
    Lewis, Dana
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (02): : 500 - 503
  • [22] DIGITAL-TOOL-SUPPORTED BASAL INSULIN TITRATION: REAL-WORLD EFFECTIVENESS OF MY DOSE COACH™ (MDC) IN PEOPLE WITH TYPE 2 DIABETES (T2D) IN INDIA
    Unnikrishnan, A. G.
    Farishta, F.
    Gupta, P.
    Ghosh, R.
    Zhou, F. L.
    Summers, M.
    Paranjape, S.
    Barbe, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A159 - A160
  • [23] EFFECTIVENESS OF MY DOSE COACH (MDC) USE DURING BASAL INSULIN (BI) TITRATION IN TYPE 2 DIABETES (T2D): REAL-WORLD DATA FROM ALGERIA, COLOMBIA, INDIA AND MEXICO
    Viswanathan, V.
    Unnikrishnan, A. G.
    Lubwama, R.
    Zhou, F. L.
    Bertolini, M.
    Botero, J.
    Mancillas-Adame, L.
    Baghous, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A30 - A31
  • [24] Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database
    Gibble, Theresa Hunter
    Chinthammit, Chanadda
    Ward, Jennifer M.
    Cappell, Katherine
    Sedgley, Robert
    Bonafede, Machaon
    Liao, Birong
    Hankosky, Emily R.
    DIABETES OBESITY & METABOLISM, 2025,
  • [25] AUTOMATED INSULIN TREATMENT IN WOMEN WITH TYPE 1 DIABETES: EVIDENCE FROM REAL-WORLD DATA
    Brown, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A22 - A22
  • [26] Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis
    Yang, Qin
    Zeng, Baoqi
    Hao, Jiayi
    Yang, Qingqing
    Sun, Feng
    DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3753 - 3763
  • [27] REAL WORLD INCIDENCE OF TYPE 2 DIABETES (T2D) COMPLICATIONS LEADING TO HOSPITALIZATION IN FRANCE: THE RECODE STUDY
    Bouee, S.
    Cochinaire, A.
    Godard, C.
    Sabater, F. J.
    Amelineau, E.
    Emery, C.
    Cotte, F. E.
    VALUE IN HEALTH, 2013, 16 (07) : A434 - A434
  • [28] Real-World Use of Canagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Harris, Stewart B.
    Reichert, Sonja
    Mequanint, Selam M.
    Spaic, Tamara
    Esler, Jim
    DIABETES, 2017, 66 : A328 - A329
  • [29] Real-World Use of Dapagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Spaic, Tamara
    Harris, Stewart B.
    Mequanint, Selam
    Reichert, Sonja
    Miller, Kristina
    DIABETES, 2017, 66 : A327 - A328
  • [30] REAL WORLD TOLERABILITY AND EFFECTIVENESS OF EXENATIDE ONCE WEEKLY COMPARED TO BASAL INSULIN AMONG ELDERLY PATIENTS WITH TYPE 2 DIABETES (T2D)
    Seeger, J. D.
    Loughlin, A. M.
    Qiao, Q.
    Nunes, A. P.
    Ezzy, S.
    Yochum, L. A.
    Clifford, C. R.
    Gately, R.
    Ohman, P.
    Dore, D. D.
    VALUE IN HEALTH, 2016, 19 (07) : A668 - A668
12345